Shared Lunch: Growing pains for medicinal cannabis
Medicinal Cannabis is a fledgling industry with lots of players and NZ is starting to make its mark on the world stage.
We talk to CEO Mark Lucas from listed player Cannasouth about going from start-up to entering the commercialisation phase, regulatory hurdles and global aspirations.
Plus Cannasouth’s proposed merger with Eqalis Group and plans for a further capital raise.
Brought to you by Sharesies, with BusinessDesk
Shared Lunch is hosted by BusinessDesk journalists including Frances Cook.
Each week, we’ll alternate between an interview with a company leader and an industry deep dive.
Tune in on YouTube to watch or subscribe to the podcast on Spotify, Google Podcasts, or Apple Podcasts.
Ok, now for the legal bit
Appearance on Shared Lunch is not an endorsement by Sharesies of the views of the presenters, guests, or the entities they represent. Their views are their own. Shared Lunch is not financial advice. We recommend talking to a licensed financial adviser. You should review relevant product disclosure documents before deciding to invest. Investing involves risk. You might lose the money you start with. Content is current at the time.
Shared Lunch is for a New Zealand audience.
Join over 600,000 investors
